These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 122262)

  • 21. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
    Okada K; Kawaharajo K; Kasai T; Homma JY
    Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early protection by vaccines in burns.
    Jones RJ
    Br J Exp Pathol; 1971 Feb; 52(1):100-9. PubMed ID: 4993954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
    Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia.
    Chhibber S; Wadhwa S; Yadav V
    Jpn J Infect Dis; 2004 Aug; 57(4):150-5. PubMed ID: 15329446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective characteristics of the antigen common to Pseudomonas and Vibrio and significance of bacterial endotoxins in protection against selected bacterial infections.
    Sourek J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):538-47. PubMed ID: 2413656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribosomes as carriers for antigenic determinants of the surface of micro-organisms.
    Normier G; Pinel AM; Dussourd d'Hinterland L; Wigzell H; Binz H
    Dev Biol Stand; 1992; 77():79-85. PubMed ID: 1385236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.
    Meitert E; Meitert T; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):105-14. PubMed ID: 6816188
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of the common protective antigen (OEP) and toxoids of protease and elastase from Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink.
    Honda E; Homma JY; Abe C; Tanamoto K; Noda H; Yanagawa R
    Zentralbl Bakteriol Orig A; 1977; 237(2-3):297-309. PubMed ID: 403712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of resistance to respiratory tract infection with Klebsiella pneumoniae in mice fed on a diet supplemented with tulsi (Ocimum sanctum) and clove (Syzgium aromaticum) oils.
    Saini A; Sharma S; Chhibber S
    J Microbiol Immunol Infect; 2009 Apr; 42(2):107-13. PubMed ID: 19597641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of specific delayed-type hypersensitivity in Pseudomonas aeruginosa-infected mice.
    Colizzi V; Garzelli C; Campa M; Toca L; Falcone G
    Immunology; 1982 Oct; 47(2):337-44. PubMed ID: 6811422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of orally administered, Klebsiella-containing bacterial lysates in mice.
    Kuenen JD; van Dijke EE; Hol C; Bootsma HJ; Verhoef J; van Dijk H
    FEMS Immunol Med Microbiol; 1994 Jan; 8(1):69-75. PubMed ID: 8156053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nonharsh methods of isolation of antigenic complexes of Klebsiella pneumoniae, and analysis of their protective activity].
    Egorova NB; Kurbatova EA; Miroshnichenko IV; Mashilova GM; Gladus MA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Feb; (2):96-101. PubMed ID: 6340397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental sensitizing activity of Neisseria perflava].
    Ado AD; Fedoseeva VN; Chitaeva VG; Avdeeva TA
    Biull Eksp Biol Med; 1977 Aug; 84(8):191-3. PubMed ID: 71172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradermal responses to common bacterial antigens: influences of sex and clinical condition.
    Moriearty PL; Pereira C; Guimarães NA
    Ann Allergy; 1979 Aug; 43(2):115-9. PubMed ID: 37788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice.
    Vogels MT; Lindley IJ; Curfs JH; Eling WM; van der Meer JW
    Antimicrob Agents Chemother; 1993 Feb; 37(2):276-80. PubMed ID: 8452358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a.
    Ozaki Y; Ohashi T; Minami A; Nakamura S
    Infect Immun; 1987 Jun; 55(6):1436-40. PubMed ID: 3553002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pseudomonas aeruginosa. I. Isolation of P. aeruginosa in nature and animals, with special reference to mice and guinea pigs].
    Nomiya B; Kawaharajo K; Watanabe T; Tamura S
    Nihon Saikingaku Zasshi; 1972 Sep; 27(5):641-8. PubMed ID: 4199829
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nonspecific stimulation of the body's natural resistance to infection with prodigiozan].
    Bukharin OV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Sep; 43(9):54-8. PubMed ID: 4981249
    [No Abstract]   [Full Text] [Related]  

  • 40. Increase of nonspecific resistance to infection by protodyne, a protein component derived from bacterial protoplasm.
    Berger FM; Fukui GM; Ludwig BJ; Rosselet JP
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):556-9. PubMed ID: 4967029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.